SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	47	43	18	22	32	100
Market Cap Growth	29.28%	144.31%	-17.78%	-31.83%	-68.11%	353.88%
Enterprise Value	43	43	15	21	29	94
Last Close Price	0.18	0.17	0.09	0.13	0.20	0.64
PS Ratio	10.19	9.37	14.72	163.89	424.66	-
PB Ratio	5.02	4.62	5.99	10.85	12.83	19.09
P/TBV Ratio	9.21	8.48	-	16.72	17.16	21.24
EV/Sales Ratio	9.37	9.33	12.45	158.92	384.18	-
Debt / Equity Ratio	0.11	0.11	0.28	0.05	0.05	0.03
Asset Turnover	0.54	0.54	0.31	0.05	0.02	-
Inventory Turnover	2.80	2.80	2.08	0.60	-	-
Quick Ratio	4.21	4.21	0.63	3.05	4.19	11.91
Current Ratio	4.84	4.84	0.93	3.25	4.58	12.50
Return on Equity (ROE)	-11.24%	-11.24%	-115.85%	-126.85%	-72.62%	-37.31%
Return on Assets (ROA)	-8.10%	-8.10%	-46.50%	-66.02%	-42.26%	-22.00%
Return on Invested Capital (ROIC)	-9.89%	-9.89%	-61.71%	-79.79%	-46.84%	-23.93%
Return on Capital Employed (ROCE)	-10.50%	-10.50%	-85.20%	-145.30%	-115.80%	-28.10%
Earnings Yield	-1.47%	-1.60%	-16.16%	-13.10%	-8.80%	-1.44%
FCF Yield	-2.63%	-2.85%	-15.40%	-12.64%	-8.42%	-1.56%
Buyback Yield / Dilution	-22.32%	-22.32%	-13.10%	-5.06%	-6.87%	-14.53%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.